BASEL, Switzerland, Oct. 5 -- The Journal of Thrombosis and Thrombolysis, a peer-reviewed journal that says it features treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems, published research articles on the following topics in its November 2023 edition (Vol. 56, Issue 4):

* Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation